Purchase Order 75D30119P05076

Award Date 5/17/19
Potential Completion Date 6/16/19
Potential Value $100K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Nanocellect Biomedical Inc., a for-profit biotechnology company located in San Diego, California. The contract has a ceiling value of $55,000.00 and a base year performance period running from April 27, 2024 to April 26, 2029. The contract is not designated as a set-aside award. Under this contract, Nanocellect Biomedical Inc. will provide the CDC with its WOLF G2 Cell Sorter and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $147,142.50 firm fixed price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF System Cell Sorter on September 1, 2022. The contract has a completion date of September 30, 2022 and does not have a set-aside designation. Nanocellect Biomedical provides automated cell analysis, sorting, and dispensing equipment, services, and consumables to...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF G2 cell sorter. The contract has a ceiling value of $145,575.00 and a period of performance through September 30, 2024. The award was made without the use of a set-aside designation. Nanocellect Biomedical has a history of providing cell sorting equipment and services to various federal agencies,...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a $166,142.50 firm fixed-price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF G2 cell sorter and N1 single-cell dispenser. This contract does not have a set-aside designation. Nanocellect Biomedical provides automated cell analysis, sorting, and dispensing equipment, services, and consumables to support biomedical research and development across...
This is a firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency within the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The $85,000.00 contract is for the delivery of Nanocellect's WOLF and WOLF G2 cell sorting systems and N1 single-cell dispensers, along with associated maintenance services. These advanced microfluidic cell analysis tools are designed to support a wide...
The U.S. Environmental Protection Agency (EPA) awarded a $14,487.50 firm fixed-price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for a service agreement to provide a WOLF G2 cell sorter and an N1 single-cell dispenser. The contract has an ultimate completion date of January 14, 2025. Nanocellect Biomedical is an experienced federal contractor, having provided similar cell analysis equipment and services to various agencies, including the National Institutes...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $102,200.00 firm fixed price purchase order to Nanocellect Biomedical Inc., a for-profit small business organization, to provide a NanoCellect WOLF Cell Sorter and N1 Single-Cell Dispenser system as a shared instrument for the NIDCR's Combined Technical Research Core. The award has a completion date of October 14, 2017 and was made by the Department of Health and Human Services' National Institutes of Health....
This is a firm fixed price purchase order contract awarded by the Department of Agriculture Agricultural Research Service to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the provision of a NANOCELLECT WOLF CELL SORTER SYSTEM. The contract has a potential value of $117,940.00 and a completion date of August 24, 2018. The contract was not set aside for any specific business type. Nanocellect Biomedical Inc. provides automated cell analysis, sorting and dispensing equipment,...
This is a $99,950 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The contract is for a WOLF cell sorter with accessories, which will support NIAID's research initiatives in areas such as malaria, vector-borne diseases, and single-cell genomic/transcriptional analysis. This sole-source award was made...
This federal contract award, valued at $96,420.00, was made by the Northeast Area division of a civilian federal agency to Nanocellect Biomedical Inc., a for-profit biotechnology company. The award is for the delivery of a cell sorter and dispenser, including shipping, as detailed in quote number Q-000568. The original solicitation was a small business set-aside, seeking a cell sorting instrument with specific capabilities to support research across various federal agencies such as the...

This federal contract award is for the purchase of a WOLF system cell sorter from Nanocellect Biomedical Inc., a for-profit biotechnology company based in San Diego, California. The $99,765.00 fixed-price contract was awarded on May 17, 2019 by the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The award did not utilize a set-aside designation. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, including the NIH, EPA, VA, and DOD, demonstrating its expertise in delivering advanced biotechnology solutions to support government research initiatives. In addition to federal contracts, the company has also received grant funding from the National Institute of General Medical Sciences to develop AI-aided tools for biopharmaceutical cell line development, showcasing its commitment to advancing cell analysis technologies.

Generated 4/3/25, 1:09 AM